GENEVA, SWITZERLAND / ACCESS Newswire / August 11, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to ...
GENEVA, SWITZERLAND / ACCESS Newswire / June 20, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief or the Company), a biopharmaceutical company committed to delivering ...
GENEVA and LAUSANNE (Oct. 8, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief or the Company), a biopharmaceutical company committed to delivering innovative treatment ...
(RTTNews) - Relief Therapeutics Holding SA (RLFTF, RLF.SW), a biopharmaceutical company, on Tuesday said it has published a joint presentation deck ahead of the expected mid-December 2025 closing of ...
MindMaze Therapeutics secures CHF 8.0 million strategic equity financing with Neuro.io Group SA to advance neurotherapeutics solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results